Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | 19(T2)28z1xx TRAC CAR-T cells |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
19(T2)28z1xx TRAC CAR-T cells are T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting CD19 and also containing mutated immunoreceptor tyrosine-based activation motifs, which potentially leads to antitumor activity (Blood (2020) 136 (Supplement 1): 43-44). |
| DrugClasses | CD19 Immune Cell Therapy 72 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| 19(T2)28z1xx TRAC CAR-T cells | 19(T2)28z1xx TRAC CAR-T cells | 0 | 1 |